Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca exit: here's what it really means for the UK
10:47am, Wednesday, 02'nd Jul 2025
AstraZeneca Plc (LON: AZN) is in focus this morning following reports that its chief executive – Pascal Soriot is considering moving the giant's listing to the US.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 02'nd Jul 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Are these the UK's top income stocks? One leading bank thinks so
09:02am, Wednesday, 02'nd Jul 2025
Reliable income stocks are a staple of a balanced portfolio. But according to research from UBS, the UK has only a handful that warrant close attention.
Astrazeneca (AZN) Advances While Market Declines: Some Information for Investors
07:16pm, Tuesday, 01'st Jul 2025
Astrazeneca (AZN) reached $71.46 at the closing of the latest trading day, reflecting a +2.26% change compared to its last close.
Why AstraZeneca Stock Topped the Market on Tuesday
05:18pm, Tuesday, 01'st Jul 2025
Trading in AstraZeneca's (AZN 2.26%) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly liked
AstraZeneca shares pop on news CEO wants to move base to US
11:13am, Tuesday, 01'st Jul 2025
AstraZeneca PLC (LSE:AZN) shares spiked higher on Tuesday afternoon on reports that the boss of the UK pharmaceutical giant wants to move the company to the US. CEO Pascal Soriot wants to the FTSE
AstraZeneca CEO eyes US market listing, The Times reports
10:59am, Tuesday, 01'st Jul 2025
AstraZeneca chief executive Pascal Soriot is considering moving the company's stock market listing to the United States, The Times reported on Tuesday, citing multiple sources.
AstraZeneca: Navigating Challenges Across Geographies Well
09:37am, Tuesday, 01'st Jul 2025
AstraZeneca's price performance YTD exceeds the healthcare sector and broader markets, indicating investors are assuaged regarding concerns across geographies. The company has offered greater clarity
AstraZeneca's patent headwinds receding as trial data offers excitement
08:26am, Tuesday, 01'st Jul 2025
UBS has maintained its 'buy' recommendation on AstraZeneca PLC (LSE:AZN), setting a 12-month price target of 10,121p, reflecting confidence that a wave of late-stage clinical readouts will provide f
3 No-Brainer Stocks to Buy for Under $100 Right Now
06:35am, Saturday, 28'th Jun 2025
What's the biggest misconception about investing? The idea that you need a lot of money to get started is certainly a contender.
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
06:00pm, Friday, 27'th Jun 2025
VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, I
Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Thursday, 26'th Jun 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
10:46am, Tuesday, 24'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer
10:05am, Tuesday, 24'th Jun 2025
FDA expands AstraZeneca's Datroway label, making it the first TROP2-directed lung cancer therapy approved in the United States.
AstraZeneca's lung cancer trial success hailed by broker
08:23am, Tuesday, 24'th Jun 2025
AstraZeneca PLC (LSE:AZN) has scored another significant milestone in its cancer treatment programme, securing accelerated approval from the US Food and Drug Administration (FDA) for Datroway, a promi
